Abstract
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. Approximately one out of every eight American women will be diagnosed with breast cancer in their lifetime. This chapter summarizes key concepts for breast cancer screening, with an emphasis on imaging. The breast cancer screening recommendations from the most prominent medical societies are presented and summarized. Screening recommendations are broadly divided for women at average risk, at moderate risk, and at high risk for developing breast cancer in their lifetime. Guidance is provided as to what risk factors may place a woman into one of these categories. Current concepts regarding cancer screening in women with dense breasts are also discussed, as well as an overview of what can be expected when diagnostic imaging is pursued to evaluate a patient’s symptom.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute; 2012.
Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. preventive services task force. Ann Intern Med. 2009;151(10):727–37. W237–42.
American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.
Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57.
Siu AL, on behalf of the U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:279–96.
American College of Obstetricians and Gynecologists. Frequently asked questions: mammography and other screening tests for breast problems; 2016. https://www.acog.org/-/media/For-Patients/faq178.pdf. Retrieved Feb 2016.
Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.
American College of Obstetricians and Gynecologists. ACOG statement on revised American Cancer Society recommendations on breast cancer screening; 2015. http://www.acog.org/About-ACOG/News-Room/Statements/2015/ACOG-Statement-on-Recommendations-on-Breast-Cancer-Screening. Retrieved Feb 2016.
Ichikawa LE, Barlow WE, Anderson ML, et al. Time trends in radiologists’ interpretive performance at screening mammography from the community-based breast cancer surveillance consortium, 1996–2004. Radiology. 2010;256(1):74–82.
American Cancer Society. Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society; 2015. Retrieved Feb 2016.
Singletary SE. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474–82.
National Cancer Institute. Breast cancer risk assessment tool; 2011. http://www.cancer.gov/bcrisktool/. Retrieved Feb 2016.
American Cancer Society. American Cancer Society recommendations for early breast cancer detection in women without breast symptoms; 2015. http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-acs-recs. Retrieved Feb 2016.
Mainiero MB, Lourenco A, Mahoney MC, et al. American College of Radiology appropriateness criteria for breast cancer screening; 2012. https://acsearch.acr.org/docs/70910/Narrative. Retrieved Feb 2016.
National Comprehensive Cancer Network. Breast cancer screening and diagnosis, Version 1.2015; 2015. http://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf. Retrieved Feb 2016.
Tosteson AN, Fryback DG, Hammond CS, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014;174(6):954–61.
Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.
Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011;196(2):W112–6.
The Henry J. Kaiser Family Foundation. Preventive services covered by Private Health Plans under the Affordable Care Act; 2015. http://kff.org/health-reform/fact-sheet/preventive-services-covered-by-private-health-plans/. Retrieved Feb 2016.
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.
Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292(11):1317–25.
Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230(1):29–41.
Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9):807–16.
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165–75.
Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.
Sprague BL, Stout NK, Schechter C, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015;162(3):157–66.
Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.
Brem RF, Tabár L, Duffy SW, et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight study. Radiology. 2015;274(3):663–73.
D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA, et al. ACR BI-RADS atlas, breast imaging reporting and data system. Reston: American College of Radiology; 2013.
Schell MJ, Yankaskas BC, Ballard-Barbash R, et al. Evidence-based target recall rates for screening mammography. Radiology. 2007;243(3):681–9.
Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology. 2006;241(1):55–66.
Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer. 2000;89(12):2538–46.
Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 2004;231(3):813–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this chapter
Cite this chapter
Rockoff, S., Calandra, J.D. (2018). Breast Cancer Screening. In: Knaus, J., Jachtorowycz, M., Adajar, A., Tam, T. (eds) Ambulatory Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7641-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7641-6_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7639-3
Online ISBN: 978-1-4939-7641-6
eBook Packages: MedicineMedicine (R0)